Future of new AZ asthma drug uncertain after phase III failure
pharmafile | February 25, 2009 | News story | Research and Development |Â Â AZ, respiratoryÂ
Related Content
Pfizer releases results for severe RSV-associated LRTD treatment study
US-based Pfizer have announced results from its substudy B of the ongoing phase 3 clinical …
The Autumn 2020 edition of Pharmafile is available to read for free online now!
The Autumn 2020 edition of Pharmafile is available to read for free online now! 2020 …
AstraZeneca’s Calquence fails to improve survival rates in coronavirus patients
AstraZeneca’s Calquence has failed to improve survival rates and prevent lung failure in patients hospitalised …
